{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:41:45Z","timestamp":1785789705814,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1104438"],"award-info":[{"award-number":["GNT1104438"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1107510"],"award-info":[{"award-number":["GNT1107510"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1064272"],"award-info":[{"award-number":["GNT1064272"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1059660"],"award-info":[{"award-number":["1059660"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156072"],"award-info":[{"award-number":["1156072"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1174060"],"award-info":[{"award-number":["1174060"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anticonvulsant use has been linked to bone deficits in specific patient populations. We studied the association between anticonvulsant use and bone health in a population-based sample of men and women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data from 926 men (24-73\u2009yr) and 1070 women (21-94\u2009yr) participating in the Geelong Osteoporosis Study were included. Bone mineral density (BMD, g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      ) of the PA-spine and total hip was measured using dual-energy X-ray absorptiometry (Lunar). Bone quality was determined using quantitative heel ultrasound (QUS). Anthropometry was conducted and socioeconomic status was determined. Medication and lifestyle information was obtained via questionnaire. Linear regression was used to test associations between anticonvulsant use and bone health before and after adjustment for potential confounders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventeen (1.8%) men and 20 (1.9%) women reported anticonvulsant use. In men, anticonvulsant users had 9.1% lower adjusted mean BMD at the spine and hip compared to non-users. Body mass index was an effect modifier at the spine. Anticonvulsant users also had 1.8% lower speed of sound (SOS), 10.6% lower broadband ultrasound attenuation (BUA) and 13.7% lower stiffness index (SI) compared to non-users. In women, BMD tended to be lower at the hip compared to non-users as with the bone quality measure, BUA. No significant associations were observed at the spine or the other bone quality measures, SOS and SI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data suggest that bone quantity and quality, assessed using BMD and QUS, are lower for men and possibly women who use anticonvulsants. While further exploration into potential mechanisms is needed, our findings suggest that monitoring bone health among users of anticonvulsants is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-021-04042-w","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T13:05:19Z","timestamp":1613048719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Anticonvulsant use and bone health in a population-based study of men and women: cross-sectional data from the Geelong Osteoporosis Study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3910-3248","authenticated-orcid":false,"given":"Vinoomika","family":"Chandrasekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Pasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Brennan-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasika M.","family":"Samarasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"issue":"21\u201322","key":"4042_CR1","first-page":"365","volume":"112","author":"C Sch\u00fcrer","year":"2015","unstructured":"Sch\u00fcrer C, Wallaschofski H, Nauck M, V\u00f6lzke H, Schober H-C, Hannemann A. Fracture risk and risk factors for osteoporosis. Dtsch Arztebl Int. 2015;112(21\u201322):365\u201371.","journal-title":"Dtsch Arztebl Int"},{"key":"4042_CR2","doi-asserted-by":"crossref","unstructured":"Pasco JA, Holloway-Kew KL, Hyde NK, Tembo MC, Rufus PG, Sui SX, Berk M, Kotowicz MA. Pretiree lifestyles in relation to musculoskeletal health: cross-sectional data from the Geelong Osteoporosis Study. JCSM Clinical Reports. 2018;3:1-12.","DOI":"10.17987\/jcsm-cr.v3i2.72"},{"issue":"1","key":"4042_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T Sozen","year":"2017","unstructured":"Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46\u201356.","journal-title":"Eur J Rheumatol"},{"key":"4042_CR4","volume-title":"Osteoporosis costing all Australians A new burden of disease analysis \u2013 2012 to 2022","author":"J Watts","year":"2012","unstructured":"Watts J, Abimanyi-Ochom J, Sanders K. Osteoporosis costing all Australians A new burden of disease analysis \u2013 2012 to 2022. Glebe, NSW: Osteoporosis Australia; 2012."},{"issue":"Suppl 1","key":"4042_CR5","first-page":"S18","volume":"51","author":"KM Knapp","year":"2009","unstructured":"Knapp KM. Quantitative ultrasound and bone health. Salud Publica Mex. 2009;51(Suppl 1):S18\u201324.","journal-title":"Salud Publica Mex"},{"issue":"2","key":"4042_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jocd.2016.03.003","volume":"19","author":"EM Lewiecki","year":"2016","unstructured":"Lewiecki EM, Binkley N, Morgan SL, Shuhart CR, Camargos BM, Carey JJ, Gordon CM, Jankowski LG, Lee JK, Leslie WD. Best practices for dual-energy X-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry Guidance. J Clin Densitom. 2016;19(2):127\u201340.","journal-title":"J Clin Densitom"},{"issue":"1","key":"4042_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.21037\/qims.2018.02.02","volume":"8","author":"WM Oo","year":"2018","unstructured":"Oo WM, Naganathan V, Bo MT, Hunter DJ. Clinical utilities of quantitative ultrasound in osteoporosis associated with inflammatory rheumatic diseases. Quant Imaging Med Surg. 2018;8(1):100\u201313.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"4042_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1053\/jhep.2001.20533","volume":"33","author":"S Rouillard","year":"2001","unstructured":"Rouillard S, Lane NE. Hepatic osteodystrophy. Hepatology. 2001;33(1):301\u20137.","journal-title":"Hepatology"},{"key":"4042_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jad.2019.02.013","volume":"249","author":"V Chandrasekaran","year":"2019","unstructured":"Chandrasekaran V, Brennan-Olsen SL, Stuart AL, Pasco JA, Berk M, Hodge JM, Williams LJ. Bipolar disorder and bone health: a systematic review. J Affect Disord. 2019;249:262\u20139.","journal-title":"J Affect Disord"},{"issue":"6","key":"4042_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/MED.0000000000000366","volume":"24","author":"PM Dussault","year":"2017","unstructured":"Dussault PM, Lazzari AA. Epilepsy and osteoporosis risk. Curr Opin Endocrinol Diabetes Obesity. 2017;24(6):395\u2013401.","journal-title":"Curr Opin Endocrinol Diabetes Obesity"},{"issue":"1","key":"4042_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/00023210-200822010-00003","volume":"22","author":"C Johannessen Landmark","year":"2008","unstructured":"Johannessen Landmark C. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS drugs. 2008;22(1):27\u201347.","journal-title":"CNS drugs"},{"issue":"1","key":"4042_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.31887\/DCNS.1999.1.1\/hgrunze","volume":"1","author":"H Grunze","year":"1999","unstructured":"Grunze H, Schl\u00f6sser S, Amann B, Walden J. Anticonvulsant drugs in bipolar disorder. Dialogues Clin Neurosci. 1999;1(1):24\u201340.","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"4042_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1535-7597.2003.03306.x","volume":"3","author":"AM Pack","year":"2003","unstructured":"Pack AM. The association between antiepileptic drugs and bone disease. Epilepsy Curr. 2003;3(3):91\u20135.","journal-title":"Epilepsy Curr"},{"issue":"11","key":"4042_CR14","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/j.1528-1157.1998.tb01307.x","volume":"39","author":"B Stoffel-Wagner","year":"1998","unstructured":"Stoffel-Wagner B, Bauer J, Fl\u00fcgel D, Brennemann W, Klingm\u00fcller D, Elger CE. Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication. Epilepsia. 1998;39(11):1164\u201373.","journal-title":"Epilepsia"},{"issue":"4","key":"4042_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/BOR.0000000000000406","volume":"29","author":"M Hars","year":"2017","unstructured":"Hars M, Trombetti A. Body composition assessment in the prediction of osteoporotic fractures. Curr Opin Rheumatol. 2017;29(4):394\u2013401.","journal-title":"Curr Opin Rheumatol"},{"key":"4042_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bone.2014.04.018","volume":"64","author":"C Shen","year":"2014","unstructured":"Shen C, Chen F, Zhang Y, Guo Y, Ding M. Association between use of antiepileptic drugs and fracture risk: a systematic review and meta-analysis. Bone. 2014;64:246\u201353.","journal-title":"Bone"},{"issue":"7","key":"4042_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1631\/jzus.B1500021","volume":"16","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zheng Y-x, Zhu J-m, Zhang J-m, Zheng Z. Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis. J Zhejiang Univ Sci B. 2015;16(7):611\u201321.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"5","key":"4042_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s002230010027","volume":"69","author":"C Cepollaro","year":"2001","unstructured":"Cepollaro C, Gonnelli S, Bruni D, Pacini S, Martini S, Franci MB, Gennari L, Rossi S, Hayek G, Zappella M, et al. Dual X-ray absorptiometry and bone ultrasonography in patients with Rett syndrome. Calcif Tissue Int. 2001;69(5):259\u201362.","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"4042_CR19","doi-asserted-by":"publisher","first-page":"9908","DOI":"10.3390\/nu7125517","volume":"7","author":"V Vera","year":"2015","unstructured":"Vera V, Moran JM, Barros P, Canal-Macias ML, Guerrero-Bonmatty R, Costa-Fernandez C, Lavado-Garcia JM, Roncero-Martin R, Pedrera-Zamorano JD. Greater calcium intake is associated with better bone health measured by quantitative ultrasound of the phalanges in pediatric patients treated with anticonvulsant drugs. Nutrients. 2015;7(12):9908\u201317.","journal-title":"Nutrients"},{"issue":"10","key":"4042_CR20","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1111\/j.1528-1167.2007.01176.x","volume":"48","author":"LS Nissen-Meyer","year":"2007","unstructured":"Nissen-Meyer LS, Svalheim S, Tauboll E, Reppe S, Lekva T, Solberg LB, Melhus G, Reinholt FP, Gjerstad L, Jemtland R. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism. Epilepsia. 2007;48(10):1850\u201360.","journal-title":"Epilepsia"},{"issue":"6","key":"4042_CR21","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/ije\/dyr148","volume":"41","author":"JA Pasco","year":"2012","unstructured":"Pasco JA, Nicholson GC, Kotowicz MA. Cohort profile: Geelong osteoporosis study. Int J Epidemiol. 2012;41(6):1565\u201375.","journal-title":"Int J Epidemiol"},{"issue":"959","key":"4042_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1259\/bjr\/33589854","volume":"80","author":"CD Economos","year":"2007","unstructured":"Economos CD, Sacheck JM, Wacker W, Shea K, Naumova EN. Precision of lunar Achilles+ bone quality measurements: time dependency and multiple machine use in field studies. Br J Radiol. 2007;80(959):919\u201325.","journal-title":"Br J Radiol"},{"issue":"1","key":"4042_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF00310168","volume":"55","author":"CC Gluer","year":"1994","unstructured":"Gluer CC, Wu CY, Jergas M, Goldstein SA, Genant HK. Three quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int. 1994;55(1):46\u201352.","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"4042_CR24","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.7150\/ijms.6765","volume":"10","author":"K Chin","year":"2013","unstructured":"Chin K, Ima-Nirwana S. Calcaneal quantitative ultrasound as a determinant of bone health status: what properties of bone does it reflect? Int J Med Sci. 2013;10(12):1778\u201383.","journal-title":"Int J Med Sci"},{"issue":"11","key":"4042_CR25","first-page":"795","volume":"48","author":"C Wheeler","year":"1994","unstructured":"Wheeler C, Rutishauser I, Conn J, O'Dea K. Reproducibility of a meal-based food frequency questionnaire. The influence of format and time interval between questionnaires. Eur J Clin Nutr. 1994;48(11):795\u2013809.","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"4042_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00198-009-1042-7","volume":"21","author":"MJ Henry","year":"2010","unstructured":"Henry MJ, Pasco JA, Korn S, Gibson JE, Kotowicz MA, Nicholson GC. Bone mineral density reference ranges for Australian men: Geelong osteoporosis study. Osteoporos Int. 2010;21(6):909\u201317.","journal-title":"Osteoporos Int"},{"issue":"4","key":"4042_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1440-1673.2004.01351.x","volume":"48","author":"MJ Henry","year":"2004","unstructured":"Henry MJ, Pasco JA, Pocock NA, Nicholson GC, Kotowicz MA. Reference ranges for bone densitometers adopted Australia-wide: Geelong osteoporosis study. Australas Radiol. 2004;48(4):473\u20135.","journal-title":"Australas Radiol"},{"issue":"2","key":"4042_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1445-5994.1999.tb00684.x","volume":"29","author":"JA Pasco","year":"1999","unstructured":"Pasco JA, Henry MJ, Gaudry TM, Nicholson GC, Kotowicz MA. Identification of incident fractures: the Geelong osteoporosis study. Aust NZ J Med. 1999;29(2):203\u20136.","journal-title":"Aust NZ J Med"},{"key":"4042_CR29","doi-asserted-by":"crossref","unstructured":"Fan HC, Lee HS, Chang KP, Lee YY, Lai HC, Hung PL, Lee HF, Chi CS. The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism. Int J Mol Sci. 2016;17(8):1242.","DOI":"10.3390\/ijms17081242"},{"issue":"4","key":"4042_CR30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1359\/jbmr.091027","volume":"25","author":"LD Carbone","year":"2010","unstructured":"Carbone LD, Johnson KC, Robbins J, Larson JC, Curb JD, Watson K, Gass M, Lacroix AZ. Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI). J Bone Miner Res. 2010;25(4):873\u201381.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"4042_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1525-5050(03)00036-2","volume":"4","author":"AM Pack","year":"2003","unstructured":"Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav. 2003;4(2):169\u201374.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"4042_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.0013-9580.2005.23804.x","volume":"46","author":"PC Souverein","year":"2005","unstructured":"Souverein PC, Webb DJ, Petri H, Weil J, Van Staa TP, Egberts T. Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the general practice research database. Epilepsia. 2005;46(2):304\u201310.","journal-title":"Epilepsia"},{"issue":"1","key":"4042_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.amjopharm.2010.02.003","volume":"8","author":"RH Lee","year":"2010","unstructured":"Lee RH, Lyles KW, Col\u00f3n-Emeric C. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother. 2010;8(1):34\u201346.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"4042_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2165\/00003495-197612030-00003","volume":"12","author":"TJ Hahn","year":"1976","unstructured":"Hahn TJ. Bone complications of anticonvulsants. Drugs. 1976;12(3):201\u201311.","journal-title":"Drugs"},{"issue":"3","key":"4042_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/JGP.0b013e3181bf9ebd","volume":"18","author":"B Mezuk","year":"2010","unstructured":"Mezuk B, Morden NE, Ganoczy D, Post EP, Kilbourne AM. Anticonvulsant use, bipolar disorder, and risk of fracture among older adults in the veterans health administration. Am J Geriatr Psychiatry. 2010;18(3):245\u201355.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"4042_CR36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","volume":"27","author":"CM Weaver","year":"2016","unstructured":"Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, O'Karma M, Wallace TC, Zemel BS. The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int. 2016;27(4):1281\u2013386.","journal-title":"Osteoporos Int"},{"issue":"10 Suppl 4","key":"4042_CR37","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1212\/WNL.63.10_suppl_4.S24","volume":"63","author":"RD Sheth","year":"2004","unstructured":"Sheth RD. Metabolic concerns associated with antiepileptic medications. Neurology. 2004;63(10 Suppl 4):S24\u20139.","journal-title":"Neurology"},{"issue":"10","key":"4042_CR38","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/gerona\/62.10.1172","volume":"62","author":"S Hartikainen","year":"2007","unstructured":"Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172\u201381.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"Suppl 2","key":"4042_CR39","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.yebeh.2003.11.029","volume":"5","author":"AM Pack","year":"2004","unstructured":"Pack AM, Morrell MJ. Epilepsy and bone health in adults. Epilepsy Behav. 2004;5(Suppl 2):S24\u20139.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"4042_CR40","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/epi.14015","volume":"59","author":"H Fernandez","year":"2018","unstructured":"Fernandez H, Mohammed HT, Patel T. Vitamin D supplementation for bone health in adults with epilepsy: a systematic review. Epilepsia. 2018;59(4):885\u201396.","journal-title":"Epilepsia"},{"issue":"11","key":"4042_CR41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","volume":"6","author":"MJ Bolland","year":"2018","unstructured":"Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6(11):847\u201358.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"4042_CR42","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/epi.12351","volume":"54","author":"AA Lazzari","year":"2013","unstructured":"Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy\u2014antiepileptic drug and osteoporosis prevention trial. Epilepsia. 2013;54(11):1997\u20132004.","journal-title":"Epilepsia"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04042-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-021-04042-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04042-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T21:37:10Z","timestamp":1697837830000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04042-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4042"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04042-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-48845\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-48845\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-48845\/v2","asserted-by":"object"}]},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"23 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Human Research Ethics Committee at Barwon Health. All participants provided informed, written consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has any relevant conflicts of interest related to the work under consideration for publication. JAP has received speaker fees from Amgen, Eli Lilly and Sanofi-Aventis and funding from the Geelong Region Medical Research Foundation, Barwon Health, Perpetual Trustees, The University of Melbourne, Deakin University, ANZ Charitable Trust, the American Society for Bone and Mineral Research, Amgen (Europe), GmBH, the BUPA Foundation, Osteoporosis Australia, Australia and New Zealand Bone and Mineral Society and the NHMRC. SLB-O has received Honorarium fees from Amgen Australia and Pfizer Australia, and Grant\/Research support from the University of Melbourne, Deakin University, Arthritis Victoria, Arthritis Australia, Australian Association of Gerontology, and the City of Greater Geelong. MB has received Grant\/Research Support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, Medical Benefits Fund, National Health and Medical Research Council, Medical Research Futures Fund, Beyond Blue, Rotary Health, A2 milk company, Meat and Livestock Board, Woolworths, Avant and the Harry Windsor Foundation, has been a speaker for Astra Zeneca, Lundbeck, Merck, Pfizer, and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Lundbeck Merck, Pfizer and Servier. LJW has received Grant\/Research support from Eli Lilly, Pfizer, The University of Melbourne, Deakin University and the NHMRC. VC, ALS, JH and RS have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}